Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Aug 26, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.8K

Management of pelvic sarcoma.

Jay S Lee1, Ciara M Kelly2, Edmund K Bartlett3

  • 1Department of Surgery, Duke University, Durham, NC, USA.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|October 4, 2022
PubMed
Summary

Pelvic sarcomas, rare soft tissue and bone tumors, require specialized multidisciplinary care. Surgical resection with wide margins is key, but multimodal treatment is critical due to high local recurrence risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Cancer medicine·2026
Same author

Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial.

Annals of surgical oncology·2026
Same author

On the survival benefit from sentinel node biopsy for melanoma.

The Lancet. Oncology·2026
Same author

The promise of immunotherapy in the treatment of sarcoma: A state-of-the-art review of practice changing research and future directions.

Human vaccines & immunotherapeutics·2026
Same author

Perspective Editorial: Assessment of Survival Benefit from Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-analysis.

Annals of surgical oncology·2026
Same author

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal for immunotherapy of cancer·2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Orthopedic Oncology

Background:

  • Pelvic sarcomas are rare, heterogeneous tumors comprising soft tissue and bone types.
  • Common soft tissue pelvic sarcomas include liposarcoma, leiomyosarcoma, and gastrointestinal stromal tumors.
  • Common bone sarcomas of the pelvis include osteosarcoma and chondrosarcoma.

Purpose of the Study:

  • To highlight the complexity of pelvic sarcoma management.
  • To emphasize the importance of specialized treatment centers.
  • To outline the cornerstone treatment modalities and challenges.

Main Methods:

  • Review of common pelvic sarcoma subtypes.
  • Discussion of diagnostic and management principles.
  • Emphasis on surgical resection and multimodal treatment strategies.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.2K

Related Experiment Videos

Last Updated: Aug 26, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.8K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.2K

Main Results:

  • Pelvic sarcomas are diverse, necessitating tailored management based on histology and grade.
  • Surgical resection with wide margins is the primary treatment, though anatomically challenging.
  • Multimodal therapy is essential to mitigate the high risk of local recurrence.

Conclusions:

  • Effective management of pelvic sarcomas demands a multidisciplinary approach at experienced centers.
  • Histologic type and grade are crucial determinants of treatment strategy.
  • Addressing the high risk of local recurrence requires comprehensive, multimodal treatment plans.